Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ADM Protexin is a leading specialist in the research and manufacture of innovative, research-based probiotics for human and animal health. Based in Somerset, United Kingdom, the company operates high-specification fermentation and manufacturing facilities dedicated to producing high-quality live bacteria supplements. Their flagship brands, including Bio-Kult and Lepicol, are supported by clinical trials focusing on indications such as irritable bowel syndrome, migraines, and cognitive health. Since its acquisition by ADM in 2018, the company has integrated its microbial expertise into ADM's broader Health & Wellness portfolio to advance microbiome-based solutions. ADM Protexin serves a global market across healthcare, retail, and veterinary channels, maintaining a strong focus on scientific validation and product stability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ADM Protexin.